We seek to improve sexual health and wellness by providing convenient access to high-quality testing that prioritizes clinical integrity and consumer convenience. Our solutions are designed to break down screening barriers through discreet patient-tailored digital approaches that complement traditional brick-and-mortar care. In addition to our binx io molecular point-of-care (POC) diagnostic platform for chlamydia and gonorrhea, the two most notifiable STI conditions in the United States in 2019, we offer a comprehensive digital program that includes access to evidence-based testing, counseling, treatment, and follow up aimed at increasing testing and reducing infection spread.

Want to learn more?

Explore our handy FAQs, learn more about our proprietary POC devices, or reach out today.